Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of OROS, TTS, and IR Oxybutynin in Women with Urinary Incontinence
NCT00304499Phase 3Completed
- Sponsor
- ALZA Corporation
- Start
- Dec 1995
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxybutynin in urinary incontinence (UI), sponsored by ALZA Corporation. Started Dec 1995; status: completed.
02
Drugs
oxybutynin
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NCT00304499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304499.